AboutTeamInvestmentsNewsContact
AboutTeamInvestmentsNewsContact

Sweden Fidelio Capital Sturegatan 10 114 36 Stockholm

United Kingdom Fidelio Capital 14-16 Bruton Place London W1J 6LX

United States Fidelio Capital 250 West 55th Street, 17th Floor New York, NY 10019

Morenews
logo
News
2025-07-28
Fidelio increases ownership in Greenfood
Fidelio increases the ownership in the Greenfood, further expanding a partnership which started in 2012. With this, Fidelio becomes the majority owner, taking over from Nordic Capital.
logo
News
2025-07-01
Fidelio invests in Alphalyse to support global growth in biologic drug analytics
Fidelio has acquired a majority stake in Alphalyse, a Danish specialist contract research organisation (CRO) focused on liquid-chromatography mass-spectrometry (LC-MS) based analytics.
logo
News
2025-06-26
Odevo expands to southern Europe and Latin America as Portik joins the group
Odevo continues its international expansion with entry into Spain, Italy, Mexico, and Portugal as Portik is added to the group. Portik is a fast-growing company that has built a strong presence across fragmented markets by consistently delivering value to homeowners and residents.
logo
AboutTeamInvestmentsNewsContact
Privacy policyCookie policyTerms & conditionsSFDR Statement

Sweden
Fidelio Capital
Sturegatan 10
114 36 Stockholm

United Kingdom
Fidelio Capital
14-16 Bruton Place
London W1J 6LX

United States
Fidelio Capital
250 West 55th Street, 17th Floor
New York, NY 10019

Copyright © 2024 Fidelio Capital All rights reserved.

FidelioacquiresIndicalBioscience

Share

Linkedin

Email

Copy link

Fidelio acquires Indical Bioscience, a leading provider of diagnostic products specifically developed for veterinary specific applications.

The company develops and markets diagnostic solutions and products based on PCR (molecular) and ELISA (immunodiagnostic) technology. The products are used by laboratories primarily to indicate and diagnose viruses and bacteria in production animals, to counteract proliferation and contribute to better animal and human health.

Indical Bioscience is based in Germany and serves customers in 169 countries through its own sales force and commercial partners. Fidelio Capital acquired Indical Bioscience through a carve-out from Qiagen, a molecular diagnostic group listed on the NYSE and Frankfurt stock exchanges.